Are patients with hematuria appropriately referred to Urology? A multi-institutional questionnaire based survey - PubMed (original) (raw)
Are patients with hematuria appropriately referred to Urology? A multi-institutional questionnaire based survey
Alan M Nieder et al. Urol Oncol. 2010 Sep-Oct.
Abstract
Introduction: Hematuria is a common finding that may be a sign of serious underlying urologic disease. Thus, the AUA guidelines (written in conjunction with the American Academy of Family Practice) recommend urologic evaluation for patients with both microscopic and gross hematuria. We sought to evaluate practice patterns of the evaluation of hematuria by primary care physicians (PCPs) in two locations in the United States.
Methods: Anonymous questionnaires regarding use of urinalysis (UA) and evaluation of hematuria were mailed to 586 PCPs in Miami, Florida and 1,915 in Dallas, Texas. Surveys were mailed to physicians who identified themselves as practitioners of internal medicine, family practice, primary care, or obstetrics and gynecology.
Results: Surveys were completed by 788 PCPs including 270 (46%) and 518 (26%) PCPs in Miami and Dallas, respectively. Screening UAs were obtained on all patients by 77% and 64%, of physicians in Miami and Dallas, respectively. In both Miami and Dallas, only 36% of PCPs reported referring patients with microscopic hematuria to an urologist. In patients with gross hematuria, referral rates were 77% and 69% in Miami and Dallas, respectively.
Conclusions: While many PCPs use UA in many of their patients routinely, few PCPs automatically refer their patients with microscopic hematuria to urology and not all patients with gross hematuria are referred. Further investigations regarding why and when patients are referred to urology is warranted. Increasing awareness of the complete and timely evaluation of hematuria may be beneficial in preventing a delay in bladder cancer.
Copyright (c) 2010 Elsevier Inc. All rights reserved.
Similar articles
- Patterns of hematuria referral to urologists: does a gender disparity exist?
Johnson EK, Daignault S, Zhang Y, Lee CT. Johnson EK, et al. Urology. 2008 Sep;72(3):498-502; discussion 502-3. doi: 10.1016/j.urology.2008.01.086. Epub 2008 Jul 10. Urology. 2008. PMID: 18619657 - Microscopic hematuria.
Chan D, Ong A, Schoenberg M. Chan D, et al. N Engl J Med. 2003 Sep 25;349(13):1292-3; author reply 1292-3. doi: 10.1056/NEJM200309253491317. N Engl J Med. 2003. PMID: 14507957 No abstract available. - Hematuria as a Marker of Occult Urinary Tract Cancer: Advice for High-Value Care From the American College of Physicians.
Nielsen M, Qaseem A; High Value Care Task Force of the American College of Physicians. Nielsen M, et al. Ann Intern Med. 2016 Apr 5;164(7):488-97. doi: 10.7326/M15-1496. Epub 2016 Jan 26. Ann Intern Med. 2016. PMID: 26810935 - Asymptomatic microscopic hematuria in adults: summary of the AUA best practice policy recommendations.
Grossfeld GD, Wolf JS Jr, Litwan MS, Hricak H, Shuler CL, Agerter DC, Carroll PR. Grossfeld GD, et al. Am Fam Physician. 2001 Mar 15;63(6):1145-54. Am Fam Physician. 2001. PMID: 11277551 Review. - Evaluating adult hematuria.
Fickenscher L. Fickenscher L. Nurse Pract. 1999 Sep;24(9):58-65. Nurse Pract. 1999. PMID: 10507071 Review.
Cited by
- Potential of an mRNA-Based Urine Assay (Xpert® Bladder Cancer Detection1) in Hematuria Patients - Results from a Cohort Study.
Schmitz-Dräger C, Goebell PJ, Paxinos E, Bismarck E, Chen J, Balakrishnan P, Bates M, Ebert T, Schmitz-Dräger BJ, Benderska-Söder N. Schmitz-Dräger C, et al. Bladder Cancer. 2024 Mar 12;10(1):25-33. doi: 10.3233/BLC-230089. eCollection 2024. Bladder Cancer. 2024. PMID: 38993527 Free PMC article. - Unexplained hematuria in direct oral anticoagulant use: a single-center retrospective case series.
DeCamillo D, Herrel LA, Haymart B, Latfolla A, Barnes GD. DeCamillo D, et al. Res Pract Thromb Haemost. 2024 Apr 10;8(3):102404. doi: 10.1016/j.rpth.2024.102404. eCollection 2024 Mar. Res Pract Thromb Haemost. 2024. PMID: 38706780 Free PMC article. No abstract available. - Sexual dimorphism in bladder cancer: a review of etiology, biology, diagnosis, and outcomes.
Zhu S, Zhao H. Zhu S, et al. Front Pharmacol. 2024 Jan 12;14:1326627. doi: 10.3389/fphar.2023.1326627. eCollection 2023. Front Pharmacol. 2024. PMID: 38283839 Free PMC article. Review. - The Impact of the Initial Clinical Presentation of Bladder Cancer on Histopathological and Morphological Tumor Characteristics.
Jakus D, Šolić I, Jurić I, Borovac JA, Šitum M. Jakus D, et al. J Clin Med. 2023 Jun 25;12(13):4259. doi: 10.3390/jcm12134259. J Clin Med. 2023. PMID: 37445294 Free PMC article. - Free Ferrous Protoporphyrin and Reactive Oxygen Species Status of Voided Urine Predicts Higher Stage in Urothelial Carcinoma.
Zhao F, Qi N, Shen X, Xiong Z, Xue N, Xu Y, Wang J, Zhu H. Zhao F, et al. Cancer Manag Res. 2022 Feb 15;14:615-621. doi: 10.2147/CMAR.S352127. eCollection 2022. Cancer Manag Res. 2022. PMID: 35210858 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical